Arbutus Biopharma Corporation

📍 Warminster, United States👥 73 employees💰 Last funded Oct 2018
Biotechnology Research🌐 arbutusbio.com
Website LinkedIn
Arbutus Biopharma Corporation (Nasdaq: ABUS) is a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). We believe the key to success in developing a functional cure involves suppressing HBV DNA, reducing surface antigen, and boosting HBV-specific immune responses. Our pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. Imdusiran has generated meaningful clinical data demonstrating an impact on both surface antigen reduction and reawakening of the HBV-specific immune response. Imdusiran is currently in three Phase 2a combination clinical trials. AB-101 is currently being evaluated in a Phase 1a/1b clinical trial.
4
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Other investors· 4
Jim Meyers
Jim Meyers
Healthcare Executive, Board Member, Senior Advisor
Board Member
5 investments
Oct 2018
?
Board Member
2015
?
Board Member
Dec 2014
?
Member of the Board
Jan 2010
Investor geography1 country
United States
1
Investor activity2010–2018 · investors recorded per year
20101201412015120181
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Arbutus Biopharma Corporation?
Arbutus Biopharma Corporation has 4 investors on record on gritt.io.
When did Arbutus Biopharma Corporation last raise funding?
The most recent investment in Arbutus Biopharma Corporation recorded on gritt.io was in October 2018.
What industry is Arbutus Biopharma Corporation in?
Arbutus Biopharma Corporation operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Arbutus Biopharma Corporation based?
Arbutus Biopharma Corporation is headquartered in Warminster, United States.